Gutowski-Eckel Z, Bäumert H G
Institut für Biophysikalische Chemie und Biochemie, Johann-Wolfgang-Goethe-Universität, Frankfurt am Main, Germany.
Eur J Biochem. 1993 Dec 15;218(3):823-8. doi: 10.1111/j.1432-1033.1993.tb18437.x.
The Ca(2+)-ATPase from sarcoplasmic reticulum can be inhibited by adenosine 5'-[gamma-imidazolidate]triphosphate through the formation of an intramolecular cross-link at the active site which is dependent on the presence of Ca2+ [Bill, E., Gutowski, Z. & Bämert, H.G. (1988). Calcium-dependent inactivation of the Ca(2+)-ATPase from sarcoplasmic reticulum by chemically reactive adenosine triphosphate, Eur. J. Biochem. 176, 119-124] In the present study we show that adenosine 5'-[beta-imidazolidate]diphosphate is likewise an inhibitor of the Ca(2+)-ATPase effecting a similar inhibition pattern on phosphate release and Ca2+ transport. The overall reaction is Ca2+ dependent and produces a protein band that in SDS/PAGE is indistinguishable from that seen with ATP[imidazolidate]. This shows that the side chain of Asp351 which is claimed to be involved in the cross-linking reaction must be in reach of both the beta and the gamma phosphate moiety of the respective nucleotides. The cross-linked product is formed by a two-step reaction. The first step is the fast reaction of nucleotide imidazolidate presumably at the phosphorylation site (Asp351) under-formation of a mixed anhydride that covalently links nucleotide and protein. Subsequently, the nucleotide is released by a substitution reaction with a second amino acid side chain. This cross-linking reaction is strictly Ca2+ dependent and, remarkably, requires Ca2+ to be added before addition of the inhibitor. It proceeds at two rates and suggests that there are two states of the nucleotide-bindings site. This is also supported by the fact that in the absence of CA2+, ATP[imidazolidate] reacts only in approximately 50% of the calculated ATP-binding sites (based on 80-90% ATPase of total sarcoplasmic reticulum protein) with no subsequent cross-linking reaction.
肌浆网的Ca(2 +)-ATP酶可被5'-[γ-咪唑啉代]三磷酸腺苷抑制,通过在活性位点形成分子内交联,该交联依赖于Ca2 +的存在[比尔,E.,古托夫斯基,Z.和巴默特,H.G.(1988年)。化学反应性三磷酸腺苷对肌浆网Ca(2 +)-ATP酶的钙依赖性失活,《欧洲生物化学杂志》176,119 - 124]在本研究中,我们表明5'-[β-咪唑啉代]二磷酸腺苷同样是Ca(2 +)-ATP酶的抑制剂,对磷酸盐释放和Ca2 +转运产生类似的抑制模式。总体反应依赖于Ca2 +,并产生一条在SDS/PAGE中与ATP[咪唑啉代]产生的条带无法区分的蛋白质条带。这表明据称参与交联反应的Asp351侧链必须能够接触到相应核苷酸的β和γ磷酸基团。交联产物通过两步反应形成。第一步是核苷酸咪唑啉代大概在磷酸化位点(Asp351)的快速反应,形成混合酸酐,将核苷酸和蛋白质共价连接。随后,核苷酸通过与第二个氨基酸侧链的取代反应释放。这种交联反应严格依赖于Ca2 +,并且值得注意的是,需要在添加抑制剂之前添加Ca2 +。它以两种速率进行,表明核苷酸结合位点有两种状态。这也得到以下事实的支持:在没有Ca2 +的情况下,ATP[咪唑啉代]仅在大约50%的计算出的ATP结合位点(基于总肌浆网蛋白的80 - 90%的ATP酶)中反应,且随后没有交联反应。